0.7350
+0.0019
+(0.26%)
At close: April 17 at 4:00:02 PM EDT
0.7670
+0.03
+(4.35%)
After hours: April 17 at 6:34:26 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-138,200
-138,200
-93,291
-90,966
-32,519
Investing Cash Flow
86,607
86,607
-68,183
-93,249
-176,397
Financing Cash Flow
16,724
16,724
154,298
2,133
433,429
End Cash Position
16,339
16,339
51,208
58,384
240,466
Income Tax Paid Supplemental Data
--
--
170
--
11
Capital Expenditure
-6,505
-6,505
-11,613
-7,054
-3,121
Issuance of Capital Stock
15,192
15,192
152,720
--
429,847
Issuance of Debt
--
--
--
--
1,150
Repayment of Debt
--
--
--
--
-119
Free Cash Flow
-144,705
-144,705
-104,904
-98,020
-35,640
12/31/2021 - 7/23/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PRME Prime Medicine, Inc.
1.2400
0.00%
NTLA Intellia Therapeutics, Inc.
7.23
+5.39%
ALLO Allogene Therapeutics, Inc.
1.4500
+3.57%
BEAM Beam Therapeutics Inc.
17.00
+2.29%
EDIT Editas Medicine, Inc.
1.2800
+0.79%
FATE Fate Therapeutics, Inc.
1.1100
+5.71%
VERV Verve Therapeutics, Inc.
4.5900
+1.77%
IPSC Century Therapeutics, Inc.
0.5437
+8.74%
MGNX MacroGenics, Inc.
1.2600
+6.78%
NKTX Nkarta, Inc.
1.8100
+3.43%